<

INNATE PHARMA (EPA:IPH) Innate Pharma , announces today the entry in pre-clinical validation of a new drug candidate: IPH 4201, a monoclonal antibody targeting a specific antigen on pancreatic cancer cells

Transparency directive : regulatory news

01/12/2008 18:05

source : webdisclosure.com

INNATE PHARMA's latest news


17/06/2024 07:00
23/05/2024 22:00
05/04/2024 09:34
19/03/2024 07:00
21/02/2024 07:00
03/11/2023 07:00
29/08/2023 07:00
10/08/2023 07:00
10/06/2023 07:00
12/05/2023 22:00


Other stories

31/10/2024 20:24
31/10/2024 21:53
31/10/2024 14:21
31/10/2024 22:47
31/10/2024 18:45
31/10/2024 20:35
31/10/2024 22:59
31/10/2024 21:37
31/10/2024 15:51
31/10/2024 14:17
31/10/2024 22:53
31/10/2024 23:06
31/10/2024 15:19
31/10/2024 16:23
31/10/2024 18:49
31/10/2024 12:44
31/10/2024 13:18
31/10/2024 19:05
31/10/2024 18:58
31/10/2024 18:50
31/10/2024 17:48
31/10/2024 18:08
31/10/2024 15:04
31/10/2024 22:38
31/10/2024 23:58
31/10/2024 11:07
31/10/2024 23:08
31/10/2024 13:00
31/10/2024 18:02
31/10/2024 20:07
31/10/2024 14:20
31/10/2024 12:15
31/10/2024 14:05
30/10/2024 10:53
31/10/2024 15:38
31/10/2024 20:56
31/10/2024 11:44
31/10/2024 21:23